• 1
    Okuyama H, Tetuyuki K, Watanabe S. Dietary fatty acids: the n-6/n-3 balance and chronic elderly diseases: excess linoleic acid and relative n-3 deficiency syndrome seen in Japan. Prog Lipid Res 1997;35:40957.
  • 2
    Horrocks LA, Yeo YK. Health benefits of docosahexaenoic acid. Pharmacol Res 1999;40:21125.
  • 3
    Connor WE, Neuringer M, Reisbick S. Essential fatty acids; the importance of n-3 fatty acids in retina and brain. Nutr Rev 1999;50:219.
  • 4
    Mirnikjoo B, Brown SE, Seung Kim HF, et al. Protein kinase inhibition by ω-3 fatty acids. J Biol Chem 2001;276:1088896.
  • 5
    Yoshida S, Sato A, Okuyama H. Pathophysiological effects of dietary fatty acid balance on neuronal systems. Jpn J Pharmacol 1998;77:1122.
  • 6
    Voskuyl RA, Vreugdenhil M, Kang JX, et al. Anticonvulsant effect of polyunsaturated fatty acids in rats, using the cortical stimulation model. Eur J Pharmacol 1998;341:14552.
  • 7
    Xiao Y, Li X. Polyunsaturated fatty acid modify mouse hippocampal neuronal excitability during excitotoxic or convulsant stimulation. Brain Res 1999;846:11221.
  • 8
    Yehuda S, Carasso RL, Mostofski DL. Essential fatty acid preparation (SR-3) raises the seizure threshold in rats. Eur J Pharmacol 1994;254:1938.
  • 9
    Sovik O, Mansson JE, Bjorke Monsen AL, et al. Generalized peroxysmal disorder in male twins: fatty acid composition of serum lipids and response to n-3 fatty acids. J Inherit Metab Dis 1998;21:66270.
  • 10
    Young C, Gean PW, Chiou LC, et al. Docosahexaenoic acid inhibits synaptic transmission and epileptiform activity in rat hippocampus. Synapse 2000;37:904.
  • 11
    Lauritzen I, Blondeau N, Heurteaux C, et al. Polyunsaturated fatty acids are potent neuroprotectors. EMBO J 2000;19:178493.